Studies have shown that ZHX2 is negatively correlated with the expression of MDR1 in liver cancer tissue and that ZHX2 can inhibit the expression of MDR1 at the transcriptional level and promote the sensitivity of liver cancer to chemotherapy drugs [11]. This evidence concerns the gene ZHX2 and liver cancer.